Mycobacterium genavense duodenitis following allogeneic peripheral blood stem cell transplantation: Case report

Transplant Infectious Disease

Volumn 11, Issue 6, 2009, Pages 534-536

  Lu, K J ^a   Grigg, A ^a   Leslie, D ^a   Finlay, M ^a   Sasadeusz, J ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

Allogeneic stem cell transplantation; Duodenitis; Mycobacterium genavense; Opportunistic infections

Indexed keywords

BUDESONIDE; CIPROFLOXACIN; CLARITHROMYCIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; METHOTREXATE; METHYLPREDNISOLONE; METRONIDAZOLE; PREDNISOLONE; RIFABUTIN; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; ALLOGENEIC PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; ANAMNESIS; ARTICLE; CASE REPORT; CHRONIC INFLAMMATION; CLOSTRIDIUM DIFFICILE INFECTION; DISEASE ASSOCIATION; DRUG MEGADOSE; DUODENITIS; DUODENUM BIOPSY; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; LYMPHADENOPATHY; MALE; MYCOBACTERIUM GENAVENSE; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION;

DUODENITIS; GRAFT VS HOST DISEASE; HUMANS; MALE; MIDDLE AGED; MYCOBACTERIUM; MYCOBACTERIUM INFECTIONS; OPPORTUNISTIC INFECTIONS; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; POLYMERASE CHAIN REACTION; TRANSPLANTATION, HOMOLOGOUS;

EID: 71149108644     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2009.00431.x     Document Type: Article

References (12)

1. Storek J, Dawson MA, Storer B, et al. Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation. Blood 2001 97 : 3380 3389.
2. Roy V, Weisdorf D. Mycobacterial infections following bone marrow transplantation: a 20-year retrospective review. Bone Marrow Transplant 1997 19 : 467 470. (Pubitemid 27102013)
3. Au WY, Cheng VC, Ho PL, et al. Nontuberculous mycobacterial infections in Chinese hematopoietic stem cell transplantation recipients. Bone Marrow Transplant 2003 32 : 709 714.
4. Horsburgh CR Jr. Epidemiology of disease caused by nontuberculous mycobacteria. Semin Respir Infect 1996 11 : 244 251.
5. Dumonceau JM, Fonteyne PA, Realini L, et al. Species-specific Mycobacterium genavense DNA in intestinal tissues of individuals not infected with human immunodeficiency virus. J Clin Microbiol 1995 33 : 2514 2515.
6. Böttger EC, Teske A, Kirschner P, et al. Disseminated Mycobacterium genavense infection in patients with AIDS. Lancet 1992 340 : 76 80.
7. Böttger EC. Mycobacterium genavense: an emerging pathogen. Eur J Clin Microbiol Infect Dis 1994 13 : 932 936.
8. Liberek V, Soravia C, Ninet B, et al. Cervical lymphadenitis caused by M. genavense in a healthy child. Paediatr Infect Dis J 1996 15 : 269 270.
9. Bogdan C, Kern P, Richter E, et al. Systemic infection with M. genavense following immunosuppressive therapy in a patient who was seronegative for HIV. Clin Infect Dis 1997 24 : 1245 1247.
10. Krebs T, Zimmerli S, Bodmer T, Lammle B. M. genavense infection in a patient with long standing chronic lymphocytic leukemia. J Intern Med 2000 248 : 343 348.
11. Vrioni G, Nauciel C, Kerharo G, Matsiota-Bernard P. Treatment of disseminated M. genavense infection in a murine model with ciprofloxacin, amikacin, ethambutol, clarithromycin and rifabutin. J Antimicrob Chemother 1998 42 : 483 487.
12. Tartaglione T. Treatment of nontuberculous mycobacterial infections: role of clarithromycin and azithromycin. Clin Ther 1997 19 : 626 638.